Ian J Saldanha1, Rebecca Petris2, Genie Han3, Kay Dickersin4,5, Esen K Akpek6. 1. Center for Evidence Synthesis in Health, Brown University School of Public Health, Providence, Rhode Island. 2. Dry Eye Company LLC, Poulsbo, Washington. 3. Consumers United for Evidence-Based Healthcare, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. 4. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. 5. Reviews Editor. 6. Wilmer Eye Institute, Johns Hopkins School of Medicine, Baltimore, Maryland.
Abstract
Importance: Dry eye is a common ocular surface condition with significant influence on patient quality of life and societal economic burden. There is an urgent need to prioritize new research for dry eye. Objective: To identify and rank research questions and outcomes important to patients with dry eye. Design, Setting, and Participants: This study was conducted using the following 6 steps: (1) identifying research questions from a previous survey of clinicians who treat patients with dry eye; (2) identifying outcomes from existing research (systematic reviews and their cited clinical trials in the Cochrane Eyes and Vision US Satellite database of eyes and vision reviews, and National Eye Institute-funded clinical trials registered on ClinicalTrials.gov) as of June 13, 2017; (3) identifying a sample of patients with dry eye from the email subscribers to the online newsletter KeratoScoop; (4) and (5) conducting a 2-round Delphi survey of those patients online in November and December 2017, respectively; and (6) designating and ranking questions and outcomes as important. Main Outcomes and Measures: Importance assigned to research questions and outcomes for dry eye. A research question or outcome ranked by at least 75% of patients as 6 or higher on a scale of 0 to 10 was considered important. Results: Among the 420 patients from 15 countries who completed both rounds of the Delphi survey, most were 60 years of age or older (233 [56%]), female (348 [83%]), white (393 [94%]), and of non-Hispanic ethnicity (398 [95%]). Among the 12 questions that clinicians had previously prioritized, patients rated 8 as important. The top 3 questions pertained to effectiveness of patient education, environmental modifications, and topical anti-inflammatory eye drops for dry eye. Among the 109 outcomes identified in existing research on dry eye, patients rated 26 as important. Ten of these 26 were unpopular in existing research, with fewer than 10% of 158 studies reporting these outcomes. Of the 10 most important outcomes, 9 were associated with symptoms or quality of life. The 3 outcomes rated most important by patients were ocular burning or stinging, ocular discomfort, and ocular pain. Conclusions and Relevance: This study identified research questions and outcomes important to patients with dry eye. A considerable gap was noted between outcomes in existing research on dry eye and outcomes patients consider important. Future research on dry eye should consider addressing the important research questions and outcomes identified herein, taking into account the patient perspective.
Importance: Dry eye is a common ocular surface condition with significant influence on patient quality of life and societal economic burden. There is an urgent need to prioritize new research for dry eye. Objective: To identify and rank research questions and outcomes important to patients with dry eye. Design, Setting, and Participants: This study was conducted using the following 6 steps: (1) identifying research questions from a previous survey of clinicians who treat patients with dry eye; (2) identifying outcomes from existing research (systematic reviews and their cited clinical trials in the Cochrane Eyes and Vision US Satellite database of eyes and vision reviews, and National Eye Institute-funded clinical trials registered on ClinicalTrials.gov) as of June 13, 2017; (3) identifying a sample of patients with dry eye from the email subscribers to the online newsletter KeratoScoop; (4) and (5) conducting a 2-round Delphi survey of those patients online in November and December 2017, respectively; and (6) designating and ranking questions and outcomes as important. Main Outcomes and Measures: Importance assigned to research questions and outcomes for dry eye. A research question or outcome ranked by at least 75% of patients as 6 or higher on a scale of 0 to 10 was considered important. Results: Among the 420 patients from 15 countries who completed both rounds of the Delphi survey, most were 60 years of age or older (233 [56%]), female (348 [83%]), white (393 [94%]), and of non-Hispanic ethnicity (398 [95%]). Among the 12 questions that clinicians had previously prioritized, patients rated 8 as important. The top 3 questions pertained to effectiveness of patient education, environmental modifications, and topical anti-inflammatory eye drops for dry eye. Among the 109 outcomes identified in existing research on dry eye, patients rated 26 as important. Ten of these 26 were unpopular in existing research, with fewer than 10% of 158 studies reporting these outcomes. Of the 10 most important outcomes, 9 were associated with symptoms or quality of life. The 3 outcomes rated most important by patients were ocular burning or stinging, ocular discomfort, and ocular pain. Conclusions and Relevance: This study identified research questions and outcomes important to patients with dry eye. A considerable gap was noted between outcomes in existing research on dry eye and outcomes patients consider important. Future research on dry eye should consider addressing the important research questions and outcomes identified herein, taking into account the patient perspective.
Authors: Ian J Saldanha; Tianjing Li; Cui Yang; Jill Owczarzak; Paula R Williamson; Kay Dickersin Journal: J Clin Epidemiol Date: 2017-02-27 Impact factor: 6.437
Authors: Ashley Behrens; John J Doyle; Lee Stern; Roy S Chuck; Peter J McDonnell; Dimitri T Azar; Harminder S Dua; Milton Hom; Paul M Karpecki; Peter R Laibson; Michael A Lemp; David M Meisler; Juan Murube Del Castillo; Terrence P O'Brien; Stephen C Pflugfelder; Maurizio Rolando; Oliver D Schein; Berthold Seitz; Scheffer C Tseng; Gysbert van Setten; Steven E Wilson; Samuel C Yiu Journal: Cornea Date: 2006-09 Impact factor: 2.651
Authors: Priya M Mathews; Pradeep Y Ramulu; Bonnielin S Swenor; Canan A Utine; Gary S Rubin; Esen K Akpek Journal: Br J Ophthalmol Date: 2016-07-22 Impact factor: 4.638
Authors: Paul Glasziou; Douglas G Altman; Patrick Bossuyt; Isabelle Boutron; Mike Clarke; Steven Julious; Susan Michie; David Moher; Elizabeth Wager Journal: Lancet Date: 2014-01-08 Impact factor: 79.321
Authors: Paula R Williamson; Douglas G Altman; Jane M Blazeby; Mike Clarke; Declan Devane; Elizabeth Gargon; Peter Tugwell Journal: Trials Date: 2012-08-06 Impact factor: 2.279
Authors: Ian J Saldanha; Jimmy T Le; Sharon D Solomon; Michael X Repka; Esen K Akpek; Tianjing Li Journal: Ophthalmology Date: 2019-01 Impact factor: 12.079
Authors: Ian J Saldanha; Vatinee Y Bunya; Sara S McCoy; Matthew Makara; Alan N Baer; Esen K Akpek Journal: Am J Ophthalmol Date: 2020-06-20 Impact factor: 5.258